Nexstim Receives an NBT® System Order from Alamo Neurosurgical Institute
October 25, 2022 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, 25 October 2022 at 9 AM (EEST) Nexstim Receives an NBT® System Order from Alamo Neurosurgical Institute Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces...
Nexstim NBS 5+ System Continues to Generate Interest in the US
October 06, 2022 05:00 ET
|
Nexstim Oyj
Press release, Helsinki, 6 October 2022 at 12 PM (EEST) Nexstim NBS 5+ System Continues to Generate Interest in the US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that Drs....
Nexstim Receives an NBS 5+ System Order from Seattle Children’s Hospital
June 02, 2022 03:00 ET
|
Nexstim Oyj
Press release, Helsinki, 2 June 2022 at 10 AM (EEST) Nexstim Receives an NBS 5+ System Order from Seattle Children’s Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") today...
Global Deep Brain Stimulation Market Growth Opportunities Report 2022: Top 3 Growth Opportunities in the Space for Medical Device and Technology Companies to Target
May 31, 2022 06:53 ET
|
Research and Markets
Dublin, May 31, 2022 (GLOBE NEWSWIRE) -- The "Global Deep Brain Stimulation Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The study assesses the current market...
Seattle Police Department Partners With Fisher Wallace to Improve Officer Wellness
April 07, 2022 10:00 ET
|
Fisher Wallace
SEATTLE, April 07, 2022 (GLOBE NEWSWIRE) -- Today, the Seattle Police Department (SPD) has announced a strategic partnership with Fisher Wallace, the market leader in prescription wearable...
Nexstim Receives an NBS 5+ System Order from a US Customer
April 06, 2022 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, 6 April 2022 at 9 AM (EEST) Nexstim Receives an NBS 5+ System Order from a US Customer Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces having received...
Fisher Wallace Completes 2.5 Million Dollar Investment From SHUFL Capital
March 29, 2022 07:30 ET
|
Fisher Wallace Laboratories, Inc.
NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) -- Fisher Wallace Laboratories, the market leader in prescription wearable technology for the treatment of neuropsychiatric disorders, announces today the...
Nexstim Receives a System Upgrade Order from a Customer in Finland
February 16, 2022 02:30 ET
|
Nexstim Oyj
Press release, Helsinki, 16 February 2022 at 9:30 AM (EET) Nexstim Receives a System Upgrade Order from a Customer in Finland Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") has received...
Actipulse Neuroscience Joins Y Combinator
January 25, 2022 08:30 ET
|
Actipulse Neuroscience
BOSTON, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Actipulse Neuroscience, a Boston and Mexico-City-based startup pioneer in Non-Invasive Brain Stimulation therapeutics, today announces its participation in...
Worldwide Deep Brain Stimulation Devices Industry to 2026 - Key Drivers and Challenges
January 24, 2022 04:48 ET
|
Research and Markets
Dublin, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The "Global Deep Brain Stimulation (DBS) Devices Market, By Product Type (Single-channel Deep Brain Stimulator, Dual-channel Deep Brain Stimulator), By Type...